Antiepileptics in migraine prophylaxis: An updated Cochrane review

@article{Mulleners2015AntiepilepticsIM,
  title={Antiepileptics in migraine prophylaxis: An updated Cochrane review},
  author={Wim M. Mulleners and Douglas C Mccrory and Mattias Linde},
  journal={Cephalalgia},
  year={2015},
  volume={35},
  pages={51 - 62}
}
Introduction The efficacy of several antiepileptics in the preventive treatment of episodic migraine in adults has been systematically reviewed. Because many trial reports have been published since then, an updated systematic review was warranted. Methods We searched the Cochrane Central Register of Controlled Trials, PubMed/MEDLINE (1966 to January 15, 2013), MEDLINE In-Process (current week, January 15, 2013), and EMBASE (1974 to January 15, 2013) and hand-searched Headache and Cephalalgia… 

Figures and Tables from this paper

Comparison of Propranolol versus Amitriptyline as monotherapy for migraine prophylaxis
TLDR
A comparative, double-blinded, Prospective, randomized controlled study to compare the efficacy of propranolol and amitriptyline as monotherapy for the prophylaxis of migraine.
Comparison of Pregabalin and Sodium Valproate in Migraine Prophylaxis: A Randomized Double-Blinded Study
TLDR
It was showed that pregabalin, has comparable efficacy with valproate sodium in reducing migraine frequency, intensity, and duration of attacks and could be an alternative for migraine prophylaxis.
Drug safety and tolerability in prophylactic migraine treatment
TLDR
The background of the recurrence and chronification of migraine attacks has not been fully clarified, and causative preventive therapy is therefore not currently available, and the tolerability and adverse effects of the currently used medications often limit their use.
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
TLDR
Balancing the data presented in the current manuscript with additional data concerning long term safety on the one hand and cost issues on the other hand, can be of particular use to health policy makers to implement this new drug class in the prevention of migraine.
Preventive episodic migraine treatment
TLDR
A new era in the pharmacological treatment of migraine may be heralded by the monoclonal antibodies against CGRP or its receptor if the phase II results can be confirmed.
Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled trial
TLDR
Cinnarizine and sodium valproate could be useful in migraine prophylaxis in children and adolescents and should be considered effective in the prevention of migraine.
Interventions for migraine prophylaxis: protocol of an umbrella systematic review and network meta-analysis
TLDR
The result of this network meta-analysis will provide direct and indirect evidence of treatments for migraine prophylaxis, and it may provide a ranking of the treatments for patients and clinicians to help them select the best option.
Clinical Use and Monitoring of Antiepileptic Drugs.
TLDR
This review provides a general overview of the use of AEDs with a focus on the role of therapeutic drug monitoring, and discussed topics include mechanisms of action, guidelines on the clinical applications of Aeds, clinical tests available for AED Monitoring, and genetic factors known to affect AED efficacy.
Two randomized migraine studies of galcanezumab
TLDR
This study provides Class II evidence that for patients with migraine, galcanezumab (120 mg or 240 mg) given once monthly improved functioning and reduced disability.
...
...

References

SHOWING 1-10 OF 56 REFERENCES
Topiramate for the prophylaxis of episodic migraine in adults.
TLDR
The present review describes and assess the evidence from controlled trials on the efficacy and tolerability of topiramate for preventing migraine attacks in adult patients with episodic migraine and summarises data on adverse events from placebo-controlled trials and risk differences and numbers needed to harm.
Anticonvulsants in Migraine Prophylaxis: A Cochrane Review
TLDR
Anticonvulsants, considered as a class, reduce migraine frequency by about 1.3 attacks per 28 days compared with placebo, and more than double the number of patients for whom migraine frequency is reduced by ≥50% relative to placebo.
Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults.
TLDR
The present review is part of an update of a Cochrane review first published in 2004, and previously updated (conclusions not changed) in 2007, to describe and assess the evidence from controlled trials on the efficacy and tolerability of gabapentin/gabAPentin enacarbil or pregabalin for preventing migraine attacks in adult patients with episodic migraine.
Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults.
TLDR
The evidence from controlled trials on the efficacy and tolerability of antiepileptic drugs other than gabapentin, pregabalin, topiramate, and valproate for preventing migraine attacks in adult patients with episodic migraine is described and assessed.
Anticonvulsant drugs for migraine prophylaxis.
TLDR
It is demonstrated that anticonvulsants, considered as a class, reduce migraine frequency by about 1.4 attacks per 28 days as compared to placebo, and two recently published and large trials of topiramate demonstrated reasonable efficacy, and one further trial of this agent is anticipated in the near future.
Zonisamide Versus Topiramate in Migraine Prophylaxis: A Double-Blind Randomized Clinical Trial
TLDR
The results indicated that zonisamide is as effective as topiramate in migraine prophylaxis and can be considered as an alternative treatment when topiramine is not tolerated well.
Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.
TLDR
Valproate is effective in reducing headache frequency and is reasonably well tolerated in adult patients with episodic migraine.
Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study
TLDR
TPM has thus proven its efficacy and tolerability in the prophylaxis of migraine and a significant downward trend in the number of days of disability over the 16-week period of therapy.
[Effectiveness and safety of gabapentin in the preventive treatment of migraine].
TLDR
Gabapentin can be considered an effective and safe drug in the preventive treatment of migraine, as compared with their basal state.
Topiramate for migraine prevention: a randomized controlled trial.
TLDR
Topiramate showed significant efficacy in migraine prevention within the first month of treatment, an effect maintained for the duration of the double-blind phase.
...
...